Top Tweets for #Nppa
UPFSDA की जांच में अस्पताल फार्मेसियों में दवाओं की खरीद कीमत और MRP के बीच 67 गुना तक का अंतर सामने आया।
214 अस्पताल फार्मेसियों की जांच के बाद दवा कीमतों में पारदर्शिता बढ़ाने की दिशा में कदम।
#UPFSDA #NPPA #MedicinePrice #HealthNews #UttarPradesh

#IAS रोशन जैकब की बड़ी कार्यवाही 📩
उत्तर प्रदेश खाद्य सुरक्षा एवं औषधि प्रशासन (FSDA) आयुक्त IAS डॉ. रोशन जैकब ने महंगी दवाओं के खेल को रोकने और दवाओं के मनमाने दामों को काबू करने के लिए नेशनल फार्मास्युटिकल प्राइसिंग अथॉरिटी #NPPA को एक महत्वपूर्ण पत्र भेजा है।
📍IAS डॉ. रोशन जैकब ने मांग की है कि दवाओं की खरीद लागत (Procurement Price) से अत्यधिक अधिक कीमतों पर लगाम लगाने के लिए देशभर में ट्रेड मार्जिन कैपिंग (Trade Margin Capping) लागू की जाए।
📍UP में मेडिकल कॉलेजों और निजी अस्पतालों की 214 फार्मेसियों की जांच के बाद पाया गया कि कई गंभीर बीमारियों (जैसे संक्रमण, कैंसर) के महंगे इंजेक्शन्स की एमआरपी (MRP) उनके खरीद मूल्य से 5 से 67 गुना तक अधिक वसूली जा रही है। उदाहरण के लिए, ₹74 का एक इंजेक्शन करीब ₹4,980 (MRP) में बेचा जा रहा था।
📍#FSDA आयुक्त ने औषधि मूल्य नियंत्रण आदेश (DPCO)-2013 के नियमों का हवाला देते हुए दवाओं के दामों में पूर्ण पारदर्शिता लाने का आग्रह किया है ताकि मरीजों का शोषण बंद हो सके।

India's twin mechanism for governing drug prices
:An informative article by Ms Amaal Sheikh
@AmaalSheikh5
#DrugPrices #Medicines #PriceControl #DPCO #NPPA
#RetailerMargin
#Formulation #Manufacturer
#Distributor #Chemist #Hospital
#Retailer
#RightToHealth #Article21
#Law
#UPSC

16% MARGIN REMARKS: WHY ARE HOSPITAL STOCKS FALLING?
#Pharma #Healthcare #PharmaStocks #HealthcareStocks #MedicinePrice #SupremeCourt #DrugPricing #PriceControl #NPPA #StockMarket #ShareMarket #IndianStockMarket #MarketNews #PharmaSector #HealthcareSector @Miral__Solanki
The Anatomy of a 1000% Markup: When life-saving medicine becomes corporate profit -- https://t.co/9cOH0Sdb4h
#DrugPricing #PharmaTruths #AffordableHealthcare #SupremeCourtIndia #HealthcareReforms #NPPA #DPCO #CancerAwareness #PatientRights #HealthcareForAll

ఇది కేవలం దోపిడీ కాదు.. నరమేధం: ఔషధాల ధరలపై సుప్రీంకోర్టు ఆగ్రహం
@MoHFW_INDIA @Pharmadept @PMOIndia #SupremeCourt #DrugPrices #CancerDrugs #NPPA #DPCO #MedicinePrices #AffordableMedicines #CorporateHospitals #PharmaSector #IndiaNews
https://t.co/foh5dlmAqc
ఇది కేవలం దోపిడీ కాదు.. నరమేధం: ఔషధాల ధరలపై సుప్రీంకోర్టు ఆగ్రహం
@MoHFW_INDIA @Pharmadept @PMOIndia
#SupremeCourt #DrugPrices #CancerDrugs #NPPA #DPCO #MedicinePrices #AffordableMedicines #CorporateHospitals #PharmaSector #IndiaNews
https://t.co/0ZLPGlLvrf
Supreme Court Questions Huge Cancer Drug Price Gap: Rs 3,000 Drug With Rs 27,000 MRP Sparks Concern
https://t.co/EWeFNxZ1AV
#SupremeCourt #CancerDrugs #MedicinePrices #DrugPricing #DPCO #NPPA #Healthcare #CancerTreatment #IndiaNews #MedicalCosts
@livemint impact: JP Nadda reviewed trade margin rationalisation (TMR) with the dept of #pharma & #NPPA, directing them to evaluate concrete steps to curb huge markups on healthcare #consumables in view of @Tukaram_IndIAS report findings.
I report - https://t.co/QugdxC9uFe
First reported by @livemint on 15 Sep 2026 the findings of #Maharashtra FDA report pointing huge markup of 2841% on #hospital #consumables | My exclusive news break as now the Central govt has intervened to the matter. Listen.
@Tukaram_IndIAS @Pharmadept @nppa_india
'11 ರೂಪಾಯಿಗೆ ಸಿಗೋ ಐವಿ ಸೆಟ್ 325 ರೂಪಾಯಿಗೆ ಆಸ್ಪತ್ರೆಯಲ್ಲಿ ಮಾರಾಟ' ಕೇಂದ್ರ ಸರ್ಕಾರದ ಮಧ್ಯಪ್ರವೇಶಕ್ಕೆ ತುಕಾರಾಮ್ ಮುಂಧೆ ಆಗ್ರಹ
Read More: https://t.co/vLy7AFHzco
#TukaramMundhe #MaharashtraFDA #HospitalLoot #MedicalConsumables #NPPA #DPCO #ShahRukhKhan #AjayDevgn #TigerShroff #VimalAdControversy #KannadaNews

Hospital Bills Under Scanner: Mundhe Flags Huge Hospital Consumable Price Gap
#HospitalBills #HealthcareIndia #MedicalDevices #MaharashtraFDA #NPPA
Tukaram Mundhe यांचं NPPAला पत्र; वैद्यकीय साहित्याच्या किमतींवर नियंत्रणाची मागणी | Zee24Taas
#TukaramMundhe #NPPA #MaharashtraFDA #Zee24Taas
अकरा रुपयांचे सलाईन ३२५ रुपयांना, दर नियंत्रणासाठी ‘एफडीए’चे ‘एनपीपीए’ला पत्र
#FDA #FDAaction #NPPA
https://t.co/obOoGuSgmO
Maharashtra FDA Commissioner Tukaram Mundhe Writes To NPPA, Flags 2,841% Margin On IV Set, Seeks Action To Rationalise Medical Device Prices
#MaharashtraFDA #FDA #NPPA #MedicalDevices #IVSet #HospitalConsumables #Healthcare @s_amit007
https://t.co/4JM1D3lCgo
"How much margin should there be while deciding MRP should be rational, open and transparent." Maharashtra FDA Commissioner @Tukaram_IndIAS calls for greater scrutiny of trade margins, hospital markups and price monitoring. @PreetiChoudhry on #TTP.
#Exclusive #NPPA #HospitalBills #MRP #HospitalPriceMarkup
Patients are bearing the brunt of inflated MRPs on medical devices, often with little ability to negotiate prices or choose alternatives. The pricing distortion is also putting pressure on manufacturers and importers that follow transparent pricing practices, making it harder for them to compete and remain viable. The impact extends beyond individual patients: higher out-of-pocket costs, reduced competition and the potential exit of responsible suppliers could ultimately affect affordability, availability and trust in the medical-device market.
This issue needs to be spotlighted
Mundhe flags 2,841% markup on hospital #consumables, seeks #NPPA review
My exclusive news report @livemint , you first read at Mint
https://t.co/3YhwFsdlB1
@Tukaram_IndIAS @nppa_india @MoHFW_INDIA @Pharmadept
The most expensive part of a hospital bill may never touch the hospital at all.
A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue.
A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310.
These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it.
The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored.
A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone.
#PublicHealth #GoodGovernance #Leadership #TukaramMundhe
https://t.co/Ye9CVzr8qU
Mundhe flags 2,841% markup on hospital consumables, seeks NPPA review
https://t.co/3YhwFsdlB1
My exclusive news report for @livemint
#NPPA #Hospital #Consumables #Pharma
Pharma Jan Samadhan : Simplifying Grievance Redressal
A web-enabled system for consumers, distributors, dealers and retailers to raise and resolve grievances related to pharmaceuticals.
#NPPA

Pharma Sahi Daam empowers consumers to check and verify the prices of scheduled and non-scheduled medicines, helping ensure that medicines are sold at the approved prices
#PharmaSahiDaam #NPPA

Last Seen Hashtags on Sotwe
kenzie reeves
Seen from Turkey
ContaminationRemoval
Seen from United States
thundr
Seen from Netherlands
chapinas()***********************************************************************************+filter:media
Seen from United States
co92fulltime
Seen from United States
BANOSPUBLICOS
Seen from Argentina
tgirl handsfree
Seen from Turkey
wasmo
Seen from Sweden
سادي
Seen from Turkey
teenageee
Seen from Turkey
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.6M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90.1M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.5M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.5M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers


















